Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

External validation of the HANDOC score - high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{71f4db72e8334f51a3b1775811194dcd,
title = "External validation of the HANDOC score - high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis",
abstract = "Background: Invasive infections with non-beta-haemolytic streptococci (NBHS) is quite common and presents the clinicians with difficulties regarding which patients are at risk for infective endocarditis (IE). The HANDOC score was developed to identify patients with NBHS bacteraemia who are at low risk of IE. This study was conducted to validate HANDOC in an external cohort.Methods: Patients with NBHS in blood cultures between March and September 2016 in a Danish centre were included as part of an on-going study. Patient characteristics were collected to classify bacteria according to Duk{\'e}s criteria and the components of the HANDOC score were collected retrospectively from the patients' medical records.Results: 68 patients were included in the cohort, of which 16 fulfilled Duk{\'e}s criteria for IE. All patients with IE (16 of 16) had a HANDOC score above the predefined cut-off. Cases of IE were found in patients with. Streptococcus mitis, Streptococcus bovis, Streptococcus mutans, Streptococcus anginosus, and Streptococcus sanguinis group streptococci. The HANDOC score thus had a sensitivity of 100% and a specificity of 62% in this cohort.Conclusions: HANDOC has a sensitivity of 100% and a relatively high specificity (62%) also in a prospectively enrolled cohort of patients from another country than its origin. This indicates that HANDOC can be implemented in clinical practice to identify patients with a low risk of IE in whom echocardiography can be omitted.",
keywords = "Endocarditis, bacteraemia, echocardiography, management score, streptococcus",
author = "Torgny Sunnerhagen and {H{\o}jgaard Andersen}, Malene and Bruun, {Niels Eske} and Henning Bundgaard and Iversen, {Kasper Karmark} and Magnus Rasmussen",
year = "2020",
month = jan,
doi = "10.1080/23744235.2019.1679388",
language = "English",
volume = "52",
pages = "54--57",
journal = "Infectious Diseases",
issn = "2374-4235",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - External validation of the HANDOC score - high sensitivity to identify patients with non-beta-haemolytic streptococcal endocarditis

AU - Sunnerhagen, Torgny

AU - Højgaard Andersen, Malene

AU - Bruun, Niels Eske

AU - Bundgaard, Henning

AU - Iversen, Kasper Karmark

AU - Rasmussen, Magnus

PY - 2020/1

Y1 - 2020/1

N2 - Background: Invasive infections with non-beta-haemolytic streptococci (NBHS) is quite common and presents the clinicians with difficulties regarding which patients are at risk for infective endocarditis (IE). The HANDOC score was developed to identify patients with NBHS bacteraemia who are at low risk of IE. This study was conducted to validate HANDOC in an external cohort.Methods: Patients with NBHS in blood cultures between March and September 2016 in a Danish centre were included as part of an on-going study. Patient characteristics were collected to classify bacteria according to Dukés criteria and the components of the HANDOC score were collected retrospectively from the patients' medical records.Results: 68 patients were included in the cohort, of which 16 fulfilled Dukés criteria for IE. All patients with IE (16 of 16) had a HANDOC score above the predefined cut-off. Cases of IE were found in patients with. Streptococcus mitis, Streptococcus bovis, Streptococcus mutans, Streptococcus anginosus, and Streptococcus sanguinis group streptococci. The HANDOC score thus had a sensitivity of 100% and a specificity of 62% in this cohort.Conclusions: HANDOC has a sensitivity of 100% and a relatively high specificity (62%) also in a prospectively enrolled cohort of patients from another country than its origin. This indicates that HANDOC can be implemented in clinical practice to identify patients with a low risk of IE in whom echocardiography can be omitted.

AB - Background: Invasive infections with non-beta-haemolytic streptococci (NBHS) is quite common and presents the clinicians with difficulties regarding which patients are at risk for infective endocarditis (IE). The HANDOC score was developed to identify patients with NBHS bacteraemia who are at low risk of IE. This study was conducted to validate HANDOC in an external cohort.Methods: Patients with NBHS in blood cultures between March and September 2016 in a Danish centre were included as part of an on-going study. Patient characteristics were collected to classify bacteria according to Dukés criteria and the components of the HANDOC score were collected retrospectively from the patients' medical records.Results: 68 patients were included in the cohort, of which 16 fulfilled Dukés criteria for IE. All patients with IE (16 of 16) had a HANDOC score above the predefined cut-off. Cases of IE were found in patients with. Streptococcus mitis, Streptococcus bovis, Streptococcus mutans, Streptococcus anginosus, and Streptococcus sanguinis group streptococci. The HANDOC score thus had a sensitivity of 100% and a specificity of 62% in this cohort.Conclusions: HANDOC has a sensitivity of 100% and a relatively high specificity (62%) also in a prospectively enrolled cohort of patients from another country than its origin. This indicates that HANDOC can be implemented in clinical practice to identify patients with a low risk of IE in whom echocardiography can be omitted.

KW - Endocarditis

KW - bacteraemia

KW - echocardiography

KW - management score

KW - streptococcus

U2 - 10.1080/23744235.2019.1679388

DO - 10.1080/23744235.2019.1679388

M3 - Journal article

C2 - 31621444

VL - 52

SP - 54

EP - 57

JO - Infectious Diseases

JF - Infectious Diseases

SN - 2374-4235

IS - 1

ER -

ID: 59450551